aptihealth, Inc.

Aptihealth, Inc. specializes in integrated behavioral healthcare services, offering personalized care plans and medication management to enhance mental health support for individuals aged 5 and older. Aptihealth provides specialized behavioral healthcare services to individuals. Founded in 2017 and headquartered in Boston, US, the company has undergone strategic growth.

Dan Pickett serves as both founder and CEO. The company raised USD 50. 00 mn in Series B funding on November 17, 2021, from investors including Claritas Capital, OTV, Pivotal Life Sciences, Takeda Ventures, Vista Equity Partners, and What If Ventures, bringing the total amount raised to USD 50. 00 mn with a current valuation of USD 81.

79 mn. Aptihealth offers a comprehensive suite of integrated behavioral healthcare services tailored for individuals aged 5 and older. Their primary service includes personalized, goal-oriented care plans that allow users to access video therapy and online scheduling. Additionally, the company provides medication management services through licensed psychiatric prescribers, ensuring coordinated care with physicians and specialists.

Innovative assessment tools enhance understanding of patient needs, promoting engagement in self-care and treatment. Their services are marketed to health plans, health systems, and primary care providers across the US, addressing the significant mental health burden on the healthcare system. Aptihealth generates revenue primarily through partnerships with health plans and health systems. Their subscription-based model allows healthcare entities to collaborate with aptihealth to deliver integrated behavioral healthcare services.

Partnerships typically involve transaction agreements that outline service delivery terms, pricing, and reimbursement, ensuring a streamlined financial relationship. Specific pricing structures are customized within these agreements to meet the diverse needs of partnering organizations and their patient populations. Following the Series B funding round in November 2021, aptihealth intends to utilize the USD 50. 00 mn to enhance investments in clinical science, technology, and services.

This will facilitate secure collaboration at scale among patients, providers, community organizations, and health plans. The company plans to further expand its offerings and reach into new markets, although specific geographic regions for expansion have not yet been detailed.